Medpace Holdings, Inc.

NASDAQ (USD): Medpace Holdings, Inc. (MEDP)

Last Price


Today's Change

0.00 (0.00%)

Day's Change

0.00 - 0.00

Trading Volume



Exchange:  NASDAQ Global Select NASDAQ Global Select

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare


CEO:  Dr. August James Troendle M.D. Dr. August James Troendle M.D.

Full Time Employees:  5,800 5,800

IPO Date:  2016-08-11 2016-08-11

CIK:  0001668397 0001668397

ISIN:  US58506Q1094 US58506Q1094

CUSIP:  58506Q109 58506Q109

Beta:  1.36 1.36

Last Dividend:  0.00 0.00

Dcf Diff:  28.74 28.74

Dcf:  415.74 415.74


Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.


5375 Medpace Way,
Cincinnati, OH 45227, US

513 579 9911

Be the first to like this. Showing 0 of 0 comments

Post a Comment